<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:Courier;
panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:TT3Ao00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:TT39o00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:TT34o00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:TT35o00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:TT36o00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:TT37o00;
panose-1:0 0 0 0 0 0 0 0 0 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri","sans-serif";
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-AU link=blue vlink=purple><div class=WordSection1><p class=MsoNormal style='text-autospace:none'><span style='font-size:15.0pt;font-family:TT34o00'>Prostate Cancer Imaging Workshop<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:11.5pt;font-family:TT35o00'>In conjunction with MICCAI 2011<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:11.5pt;font-family:TT36o00'>When: </span><span style='font-size:11.5pt;font-family:TT37o00'>September 22, 2011<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:11.5pt;font-family:TT36o00'>Where: </span><span style='font-size:11.5pt;font-family:TT37o00'>Toronto, Canada<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00'>CALL FOR PAPERS:<span style='color:#1F497D'><o:p></o:p></span></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00'>Prostatic adenocarcinoma (CAP) is the second most common malignancy and the most frequently diagnosed cancer<span style='color:#1F497D'> </span>among men, with an estimated 190,000 new cases in the USA in 2010 (Source: American Cancer Society). September<span style='color:#1F497D'> </span>is prostate cancer awareness month, and we will be holding this workshop to discuss the latest prostate cancer<span style='color:#1F497D'> </span>imaging research. If CAP is detected early, men have a high five-year survival rate. Unfortunately, there is no<span style='color:#1F497D'> </span>standardized image-based screening protocol for early detection of CAP (unlike for breast cancers). In the USA high<span style='color:#1F497D'> </span>levels of prostate-specific antigen (PSA) warrant a trans-rectal ultrasound (TRUS) biopsy to enable histologic<span style='color:#1F497D'> </span>confirmation of presence or absence of CAP. TRUS biopsy incorporates significant random and systematic error.<span style='color:#1F497D'> </span>Random error occurs because the prostate is biopsied without knowledge of the cancer location; systematic error<span style='color:#1F497D'> </span>because certain areas (apex, transition zone, anterior fibrostroma) are under-sampled. There have been recent rapid<span style='color:#1F497D'> </span>developments in multi-parametric radiological imaging techniques (spectroscopy, dynamic contrast enhanced MR<span style='color:#1F497D'> </span>imaging, diffusion-weighting, PET, and ultrasound), that allow high resolution functional and metabolic imaging of<span style='color:#1F497D'> </span>benign and malignant prostate tissue. Distinct computational and technological challenges for multi-modal data<span style='color:#1F497D'> </span>registration and classification still remain in leveraging these multi-parametric data for optimizing biopsy and directing therapy.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:9.5pt;font-family:TT3Ao00'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>We invite submissions that address specific problems related to technologies</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>for early detection, diagnosis, prognosis, and image guided interventions for</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>treatment and biopsy of prostate cancer. Topics of interest include, but are</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>not limited to:<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:Courier;color:red'>- </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Image Segmentation, Registration of Multi-parametric MRI and 2D/3D</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>ultrasound<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:Courier;color:red'>- </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Validation of prostate segmentation and classification with registered</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>3D histological images<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:Courier;color:red'>- </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Shape analysis and morphology in prostate imaging<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:Courier;color:red'>- </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Optimizing image-guided targeted prostate cancer diagnosis and computer-aided detection, diagnosis<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:Courier;color:red'>- </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Robot assisted prostate interventions, Radiation therapy planning and guidance<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:black'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:black'>PLENARY SPEAKERS<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Professor Masoom A. Haider, MD, Faculty of Medicine, University of Toronto, University of Toronto ( <a href="http://www.radonc.utoronto.ca/our-community/faculty/faculty-profiles/haider-masoom">http://www.radonc.utoronto.ca/our-community/faculty/faculty-profiles/haider-masoom</a> ) <o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Assoc. Professor David A. Jaffray, PhD, Department of Medical Biophysics, University of Toronto, Head, Radiation Physics Department, Princess Margaret Hospital ( <a href="http://www.uhnresearch.ca/researchers/profile.php?lookup=2716">http://www.uhnresearch.ca/researchers/profile.php?lookup=2716</a> )<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>SUBMISSION OF PAPERS:<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Two types of submissions are encouraged (a) Regular papers (8-12 pages), and (b) Abstracts (up to 2 pages). The</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>abstract styled submission is specifically to encourage clinicians and MD to participate in this workshop. All</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>submissions (regular or abstract) may be submitted through the workshop website</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>(</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:blue'><a href="http://lcib.rutgers.edu/pci2011/">http://lcib.rutgers.edu/pci2011/</a></span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>), which and should conform to the MICCAI formatting instructions: (i) Papers</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'> </span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>should be in the LNCS style and submitted in PDF format, and (ii) anonymized for double blind review</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:#1F497D'>.</span><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'><o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Proceedings from last year’s workshop (Beijing) are available at <a href="http://www.amazon.com/Prostate-Cancer-Imaging-Computer-Aided-International/dp/3642159885">http://www.amazon.com/Prostate-Cancer-Imaging-Computer-Aided-International/dp/3642159885</a> .<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:black'>IMPORTANT DATES:<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Paper submission deadline: June 8, 2011<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Acceptance Notification: July 1, 2011<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Submission of the camera-ready papers: July 9, 2011<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:black'><o:p> </o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT39o00;color:black'>ORGANIZERS:<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Anant Madabhushi (Rutgers University)<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Henkjan Huisman (Radboud University Nijmegen Medical Centre)<o:p></o:p></span></p><p class=MsoNormal style='text-autospace:none'><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Dean Barratt (University College London)<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:9.5pt;font-family:TT3Ao00;color:black'>Jason Dowling (CSIRO Australian e-Health Research Center)<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='color:#1F497D'>-----------</span><o:p></o:p></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Arial","sans-serif";color:#0099CC'>Jason Dowling, PhD</span></b><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br>Research Scientist <b><span style='color:#BED600'>|</span></b> Biomedical Imaging<br>CSIRO ICT Centre, The Australian e-Health Research Centre<span style='color:#1F497D'><o:p></o:p></span></span></p><p class=MsoNormal><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><a href="http://aehrc.com/biomedical_imaging/prostate_radiotherapy.html">http://aehrc.com/biomedical_imaging/prostate_radiotherapy.html</a><br>Phone: +61 7 3253 3634 <b><span style='color:#BED600'>|</span></b> Mobile: 0427 96 44 81</span><span style='color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:9.0pt;font-family:"Arial","sans-serif";color:#0099CC'><a href="mailto:jason.dowling@csiro.au" title="mailto:olivier.salvado@csiro.au"><span style='color:#0080FF'>jason.dowling@csiro.au</span></a></span><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'> <b><span style='color:#BED600'>|</span></b> <span style='color:#0099CC'><a href="http://www.csiro.au/" title="http://www.csiro.au/"><span style='color:#0080FF'>www.csiro.au</span></a> </span><b><span style='color:#BED600'>|</span></b> <a href="http://www.aehrc.com/biomedical_imaging/" title="http://www.aehrc.com/biomedical_imaging/"><span style='color:#0080FF'>http://www.aehrc.com/biomedical_imaging/</span></a><br>Address: <span style='color:#7F7F7F'>level 5 UQ Health Science Building 901/16, Royal Brisbane and Women's Hospital, Herston, QLD, 402</span><span style='color:#1F497D'><o:p></o:p></span></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><br><b>PLEASE NOTE</b><br>The information contained in this email may be confidential or privileged. Any unauthorised use or disclosure is prohibited. If you have received this email in error, please delete it immediately and notify the sender by return email. Thank you. To the extent permitted by law, CSIRO does not represent, warrant and/or guarantee that </span><span style='font-size:9.0pt;font-family:"Arial","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>